GlassScriptPhysician profile
Gregory Michas
NPI 1285039651
$4,193.12
in general payments reported to CMS, 2019-2025
20 companies · $56.34 in 2025
The $56.34 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,432 · 2020: $538 · 2021: $22.61 · 2023: $99.77 · 2024: $43.94 · 2025: $56.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $1,191.99 | 2019-2020 | |
| Allergan, INC. | $539.04 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $369.65 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $327.16 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $288.27 | 2019-2020 | |
| Lundbeck LLC | $243.74 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $233.72 | 2019-2020 | |
| Abbvie INC. | $184.98 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $166.61 | 2019-2020 | |
| Shire North American Group INC | $165.25 | 2019 | |
| Alkermes, INC. | $95.29 | 2019-2020 | |
| Tris Pharma INC | $88.61 | 2019 | |
| Sunovion Pharmaceuticals INC. | $70.12 | 2019 | |
| Neurocrine Biosciences, INC. | $57.71 | 2019-2020 | |
| Neuronetics, INC. | $45.78 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $34.62 | 2019 | |
| Indivior INC. | $32.44 | 2019-2025 | Sublocade |
| Supernus Pharmaceuticals, INC. | $21.86 | 2025 | Qelbree |
| Neos Therapeutics, LP | $20.28 | 2019 | |
| Adlon Therapeutics L.P. | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Michas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.